Postoperative Complications After Breast Cancer Surgery and Effect on Recurrence and Survival: Population-based Cohort Study

Overview

Journal BJS Open

Publisher Oxford University Press

Specialty General Surgery

Date 2024 Dec 14

PMID 39673757

Authors

Linda Adwall

Irma Fredriksson

Hella Hultin

Maria Mani

Olov Norlen

Affiliations

Soon will be listed here.

Abstract

Background: There is conflicting evidence regarding whether postoperative complications after breast cancer surgery are associated with worse oncological outcome. This study aimed to assess the risk of systemic breast cancer recurrence after surgical site infection and also the impact of surgical site infection on locoregional recurrence, breast cancer-specific survival and overall survival.

Methods: This nationwide cohort study included patients who underwent surgery for primary breast cancer in Sweden between January 2008 and September 2019. The study cohort was identified in the Breast Cancer Database Sweden 3.0, a database linking the National Breast Cancer Quality Register to national population-based healthcare registers held by the National Board of Health and Welfare and Statistics Sweden. The primary exposure was surgical site infection within 90 days from surgery, and the primary outcome was systemic recurrence of breast cancer. Secondary outcomes included locoregional recurrence, overall survival and breast cancer-specific survival. Multivariable Cox regression analysis was performed to assess the association between exposure, predictors and outcomes.

Results: Of 82 102 patients included in the study, 15.7% experienced a surgical site infection within 90 days of surgery. Surgical site infection was not significantly associated with systemic recurrence, locoregional recurrence or breast cancer-specific survival after adjustment for confounding variables. Surgical site infection was significantly associated with worse overall survival, but the significant association disappeared in a sensitivity analysis excluding all patients with any kind of malignancy before breast cancer diagnosis.

Conclusion: Surgical site infection after breast cancer surgery does not significantly increase the risk of systemic recurrence. All possible actions should nevertheless be taken to reduce complication rates.

References

Mousa M, Barnea Y, Arad U, Inbal A, Klausner J, Menes T . Association Between Postoperative Complications After Immediate Alloplastic Breast Reconstruction and Oncologic Outcome. Clin Breast Cancer. 2018; 18(4):e699-e702. DOI: 10.1016/j.clbc.2017.11.014. View

Aguirre-Ghiso J . Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 2007; 7(11):834-46. PMC: 2519109. DOI: 10.1038/nrc2256. View

Savioli F, Edwards J, McMillan D, Stallard S, Doughty J, Romics L . The effect of postoperative complications on survival and recurrence after surgery for breast cancer: A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2020; 155:103075. DOI: 10.1016/j.critrevonc.2020.103075. View

Gupta S, King W, Korzeniowski M, Wallace D, Mackillop W . The Effect of Waiting Times for Postoperative Radiotherapy on Outcomes for Women Receiving Partial Mastectomy for Breast Cancer: a Systematic Review and Meta-Analysis. Clin Oncol (R Coll Radiol). 2016; 28(12):739-749. DOI: 10.1016/j.clon.2016.07.010. View

OConnor R, Kiely P, Dunne C . The relationship between post-surgery infection and breast cancer recurrence. J Hosp Infect. 2020; 106(3):522-535. DOI: 10.1016/j.jhin.2020.08.004. View

Beecher S, OLeary D, McLaughlin R, Sweeney K, Kerin M . Influence of complications following immediate breast reconstruction on breast cancer recurrence rates. Br J Surg. 2016; 103(4):391-8. DOI: 10.1002/bjs.10068. View

Kim R, Avivar-Valderas A, Estrada Y, Bragado P, Sosa M, Aguirre-Ghiso J . Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer. PLoS One. 2012; 7(4):e35569. PMC: 3329481. DOI: 10.1371/journal.pone.0035569. View

Teichgraeber D, Guirguis M, Whitman G . Breast Cancer Staging: Updates in the , 8th Edition, and Current Challenges for Radiologists, From the Special Series on Cancer Staging. AJR Am J Roentgenol. 2021; 217(2):278-290. DOI: 10.2214/AJR.20.25223. View

Morante Z, Ruiz R, Araujo J, Pinto J, De La Cruz-Ku G, Urrunaga-Pastor D . Impact of the Delayed Initiation of Adjuvant Chemotherapy in the Outcome of Triple Negative Breast Cancer. Clin Breast Cancer. 2020; 21(3):239-246.e4. DOI: 10.1016/j.clbc.2020.09.008. View

10.

Colleoni M, Sun Z, Price K, Karlsson P, Forbes J, Thurlimann B . Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V. J Clin Oncol. 2016; 34(9):927-35. PMC: 4933127. DOI: 10.1200/JCO.2015.62.3504. View

11.

Brooke H, Talback M, Hornblad J, Johansson L, Ludvigsson J, Druid H . The Swedish cause of death register. Eur J Epidemiol. 2017; 32(9):765-773. PMC: 5662659. DOI: 10.1007/s10654-017-0316-1. View

12.

Basith S, Manavalan B, Yoo T, Kim S, Choi S . Roles of toll-like receptors in cancer: a double-edged sword for defense and offense. Arch Pharm Res. 2012; 35(8):1297-316. DOI: 10.1007/s12272-012-0802-7. View

13.

Hanna T, King W, Thibodeau S, Jalink M, Paulin G, Harvey-Jones E . Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 2020; 371:m4087. PMC: 7610021. DOI: 10.1136/bmj.m4087. View

14.

Charlson M, Carrozzino D, Guidi J, Patierno C . Charlson Comorbidity Index: A Critical Review of Clinimetric Properties. Psychother Psychosom. 2022; 91(1):8-35. DOI: 10.1159/000521288. View

15.

Maringe C, Fowler H, Rachet B, Luque-Fernandez M . Reproducibility, reliability and validity of population-based administrative health data for the assessment of cancer non-related comorbidities. PLoS One. 2017; 12(3):e0172814. PMC: 5338773. DOI: 10.1371/journal.pone.0172814. View

16.

Adwall L, Pantiora E, Hultin H, Norlen O . Association of postoperative infection and oncological outcome after breast cancer surgery. BJS Open. 2021; 5(4). PMC: 8266532. DOI: 10.1093/bjsopen/zrab052. View

17.

Wikman H, Vessella R, Pantel K . Cancer micrometastasis and tumour dormancy. APMIS. 2008; 116(7-8):754-70. DOI: 10.1111/j.1600-0463.2008.01033.x. View

18.

Barlow L, Westergren K, Holmberg L, Talback M . The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2008; 48(1):27-33. DOI: 10.1080/02841860802247664. View

19.

Al-Hilli Z, Wilkerson A . Breast Surgery: Management of Postoperative Complications Following Operations for Breast Cancer. Surg Clin North Am. 2021; 101(5):845-863. DOI: 10.1016/j.suc.2021.06.014. View

20.

Indelicato D, Grobmyer S, Newlin H, Morris C, Haigh L, Copeland 3rd E . Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing breast conserving therapy for early-stage breast cancer. Surgery. 2007; 141(5):645-53. DOI: 10.1016/j.surg.2006.12.011. View